Dr Haijun Dong, recently appointed CEO of BioDuro-Sundia, shares his priorities for the newly merged entity, one of the largest Contract Research, Development and Manufacturing organizations (CRDMOs) in the world, his talent strategy, and the use of AI within the sector.
BioDuro has very strong capabilities on the discovery side and has a significant presence in both China and the US. Meanwhile, Sundia is extremely strong in the CMC space and has unique capabilities in terms of supporting clients with IND-enabling studies
